140 related articles for article (PubMed ID: 20563922)
1. TP53 genetic polymorphisms and environmental risk factors associated with cervical carcinogenesis in a cohort of Brazilian women with cervical lesions.
Ferreira da Silva I; Koifman RJ; Quinto Santos Souza C; Ferreira de Almeida Neto O; Koifman S
J Toxicol Environ Health A; 2010; 73(13-14):888-900. PubMed ID: 20563922
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphism of p53 and XRCC1 in cervical intraepithelial neoplasm in Taiwanese women.
Wu MT; Liu CL; Ho CK; Wu TN
J Formos Med Assoc; 2004 May; 103(5):337-43. PubMed ID: 15216398
[TBL] [Abstract][Full Text] [Related]
3. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia.
Koushik A; Ghosh A; Duarte-Franco E; Forest P; Voyer H; Matlashewski G; Coutlée F; Franco EL;
Cancer Detect Prev; 2005; 29(4):307-16. PubMed ID: 16122882
[TBL] [Abstract][Full Text] [Related]
4. TP53 genetic polymorphisms and susceptibility to cervical cancer in Bangladeshi women: a case-control study.
Apu MNH; Rashed AZM; Bashar T; Rahman MM; Mostaid MS
Mol Biol Rep; 2020 Jun; 47(6):4357-4364. PubMed ID: 32424519
[TBL] [Abstract][Full Text] [Related]
5. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India.
Saranath D; Khan Z; Tandle AT; Dedhia P; Sharma B; Contractor R; Shrivastava S; Dinshaw K
Gynecol Oncol; 2002 Aug; 86(2):157-62. PubMed ID: 12144822
[TBL] [Abstract][Full Text] [Related]
6. Development of cervical intraepithelial lesions and cervical cancer is not influenced by SOD2 RS4880 polymorhism.
Curti RRJ; Castilha EP; Bonaldo ALL; Okuyama NCM; Trugilo KP; Guembarovski RL; Couto-Filho JD; Watanabe MAE; de Oliveira KB
Pathol Res Pract; 2022 Feb; 230():153742. PubMed ID: 34959097
[TBL] [Abstract][Full Text] [Related]
7. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
8. The p53 R72P polymorphism does not influence cervical cancer development in a Portuguese population: a study in exfoliated cervical cells.
Oliveira S; Sousa H; Santos AM; Pinto D; Pinto-Correia AL; Fontoura D; Moutinho J; Medeiros R
J Med Virol; 2008 Mar; 80(3):424-9. PubMed ID: 18205229
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
[TBL] [Abstract][Full Text] [Related]
10. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
Jiang P; Liu J; Zeng X; Li W; Tang J
Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
[TBL] [Abstract][Full Text] [Related]
11. Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis.
Ueda M; Hung YC; Terai Y; Saito J; Nunobiki O; Noda S; Ueki M
Gynecol Oncol; 2005 Mar; 96(3):736-40. PubMed ID: 15721419
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis.
Lai HC; Sytwu HK; Sun CA; Yu MH; Yu CP; Liu HS; Chang CC; Chu TY
Int J Cancer; 2003 Jan; 103(2):221-5. PubMed ID: 12455036
[TBL] [Abstract][Full Text] [Related]
13. The 46359CT polymorphism of DNMT3B is associated with the risk of cervical cancer.
Hernández-Sotelo D; García-Aguilar R; Castro-Coronel Y; Magaña JJ; Leyva-Vazquez MA; Alarcón-Romero Ldel C; López-Bayghen E; Illades-Aguiar B
Mol Biol Rep; 2013 Jul; 40(7):4275-80. PubMed ID: 23677709
[TBL] [Abstract][Full Text] [Related]
14. Selected risk factors, human papillomavirus infection and the p53 codon 72 polymorphism in patients with squamous intraepithelial lesions in northeastern Thailand.
Settheetham-Ishida W; Yuenyao P; Tassaneeyakul W; Kanjanavirojkul N; Thawmor A; Kularbkaew C; Hahvajanawong C; Settheetham D; Wattanathorn J; Kashima T; Ishida T
Asian Pac J Cancer Prev; 2006; 7(1):113-8. PubMed ID: 16629527
[TBL] [Abstract][Full Text] [Related]
15. Roles of CDKN1A gene polymorphisms (rs1801270 and rs1059234) in the development of cervical neoplasia.
Vargas-Torres SL; Portari EA; Silva AL; Klumb EM; da Rocha Guillobel HC; de Camargo MJ; Santos-Rebouças CB; Russomano FB; Macedo JM
Tumour Biol; 2016 Aug; 37(8):10469-78. PubMed ID: 26846214
[TBL] [Abstract][Full Text] [Related]
16. Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited.
Koshiol J; Hildesheim A; Gonzalez P; Bratti MC; Porras C; Schiffman M; Herrero R; Rodriguez AC; Wacholder S; Yeager M; Chanock SJ; Burk RD; Wang SS
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1631-7. PubMed ID: 19423538
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women.
Mostaid MS; Mumu SB; Haque MA; Sharmin S; Jamiruddin MR; Sayedur Rahman GM; Reza HM
PLoS One; 2021; 16(12):e0261984. PubMed ID: 34962972
[TBL] [Abstract][Full Text] [Related]
18. Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk.
Laprano TD; Lemos EH; Cunha LM; Júnior JE; de SousaTeles RA; Rabenhorst SH
Tumour Biol; 2014 Aug; 35(8):7435-40. PubMed ID: 24782034
[TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica.
Ung A; Kramer TR; Schiffman M; Herrero R; Bratti MC; Burk RD; Swanson CA; Sherman ME; Hutchinson ML; Alfaro M; Morales J; Balmaceda I; Hildesheim A
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):249-53. PubMed ID: 10090303
[TBL] [Abstract][Full Text] [Related]
20. FOXP3 immunoregulatory gene variants are independent predictors of human papillomavirus infection and cervical cancer precursor lesions.
Cezar-Dos-Santos F; Ferreira RS; Okuyama NCM; Trugilo KP; Sena MM; Pereira ÉR; Pereira APL; Watanabe MAE; de Oliveira KB
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2013-2025. PubMed ID: 31177386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
